The University of Nevada, Reno School of Medicine

FC24 Jak to the Future Advancing Alopecia Areata Care with Oral Jak Inhibitors

MD, PhD

Describe the latest clinical evidence for the efficacy and safety of oral JAK inhibitors in the management of alopecia areata (AA).

Identify appropriate patients with AA for oral JAK inhibitors based on AA disease severity 

Select appropriate dose adjustment strategies to optimize treatment of AA with oral JAK inhibitors

Review shared decision-making approaches to promote patient-centered care with oral JAK inhibitors 

large_image (3).png

medium_image (3).png

small_image (3).png

thumbnail_image (3).png

image (3).png

JAK Inhibitors

On-Demand CME Videos

FC24: JAK to the Future: Advancing Alopecia Areata Care with Oral JAK Inhibitors: An Online Activity

Alopecia

derm2derm

Acne

Aesthetics

Actinic Keratoses

Atopic Dermatitis

Melanoma

Warts

Psoriasis

Psoriatic Arthritis

Rosacea

Skin Cancer

Vitiligo

View All

Conditions

CME & Education

Conferences

News

Videos

Podcasts

Cases

Content

DermToolkit

Journals

Job Board

PA & NP

Early Career

Weekly Competitions

Patient First Communication

Membership

Quick Reference Charts

Discount Pharmacies

Resources

PA/NP

Early-Career

Access Management

Career Services

Patient-First Communication

Practice Management

CME Mission

Our Accreditation Partners

Our Purpose

Our Faculty

Our Offerings

Contact Us

About

FC24: JAK to the Future: Advancing Alopecia Areata Care with Oral JAK Inhibitors: An Online Activity

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures